author-photo

Cornelia Liedtke

Charité
University of Münster

279

Papers

8155

Citations

Citation Trend

Filter By

Papers (279) Sort By

Journal Conference Others

Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer: The REACT Randomized Clinical Trial.

2021 JAMA Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Immune Markers and Tumor-Related Processes Predict Neoadjuvant Therapy Response in the WSG-ADAPT HER2-Positive/Hormone Receptor-Positive Trial in Early Breast Cancer

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (0)
Gene Expression Profiling as an Emerging Diagnostic Tool to Personalize Chemotherapy Selection for Early Stage Breast Cancer

2020
- Cornelia Liedtke
- Lajos Pusztai
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PD8-02: Residual axillary involvement in early breast cancer in patients with positive sentinel nodes after neoadjuvant chemotherapy (NACT)

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract GS5-06: No survival benefit of chemotherapy escalation in patients with pCR and “high-immune” triple-negative early breast cancer in the neoadjuvant WSG-ADAPT-TN trial

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (5)
West German Study PlanB Trial: Adjuvant Four Cycles of Epirubicin and Cyclophosphamide Plus Docetaxel Versus Six Cycles of Docetaxel and Cyclophosphamide in HER2-Negative Early Breast Cancer

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (32)
Abstract P6-03-06: Androgen supplementation in patient derived xenografts in androgen receptor positive breast cancer to increase engraftment and growth rate

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P3-12-22: Targeted intraoperative radiotherapy (TARGIT IORT) during breast conserving surgery for early stage breast cancer in patients with breast augmentation with implants

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis

2019 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (19)
Abstract PD8-03: Conversion rates from positive to negative axillary involvement in breast cancer patients presenting with biopsy-proven axillary metastases prior to primary systemic therapy (PST) – A transSENTINA subproject

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)